A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
